Ownership history in Prosight Management, LP · 5 quarters on record
This page tracks every 13F SEC filing in which Prosight Management, LP reported a position in CYTOMX THERAPEUTICS INC (CTMX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 564,800 | -2,952,313 | -83.9% | 0.42% | $1.8M | $3.19 |
| 2025 Q2 | REDUCED | 3,517,113 | -412,895 | -10.5% | 1.95% | $8.0M | $2.27 |
| 2025 Q1 | ADDED | 3,930,008 | +25,008 | +0.6% | 0.82% | $2.5M | $0.64 |
| 2024 Q4 | ADDED | 3,905,000 | +882,891 | +29.2% | 1.11% | $4.0M | $1.03 |
| 2024 Q3 | INITIATED | 3,022,109 | — | — | 0.88% | $3.6M | $1.18 |
As of 2025 Q4 — sorted by position size